Actual Medicinal Product (AMP) Palladone SR 8mg capsules (Napp Pharmaceuticals Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from light and store in airtight containers.

Provenance

This compatibility recommendation is derived from Palladone SR 8mg capsules (Napp Pharmaceuticals Ltd).

Generic
Hydromorphone
Formulation
Hydromorphone 8mg modified-release capsules
  • Hydromorphone
    • Hydromorphone 8mg modified-release capsules

      • Palladone SR 8mg capsules (Napp Pharmaceuticals Ltd)